Christoph Westphal - Profile and Investment Details

Investor Profile

Christoph Westphal is a Venture Capital, Founder, Investor based in United States with a diverse investment portfolio that includes companies such as Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology, Alnara Pharmaceuticals, Colorescience, Calithera Biosciences, Bicycle Therapeutics, PTC Therapeutics, Flex Pharma, ArcherDX, Sitryx TherapeuticsKalVista Pharmaceuticals, ImmuneID, XyloCor Therapeutics, Werewolf Therapeutics, Advion Inc., Renovia, Grail, Axial Biotherapeutics, Channel Medsystems, IlluminOss Medical, Millendo Therapeutics, Be Biopharma, Twentyeight-Seven Therapeutics, Recros Medica, TScan Therapeutics, Pyxis Oncology, . Over time, Christoph Westphal has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Christoph Westphal is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Health Diagnostics, Medical, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Christoph Westphal, as their portfolio suggests a familiarity and interest in this area.

Understanding Christoph Westphal’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.